Fulcrum Therapeutics, Inc. (FULC)
10.77
+0.17
(+1.60%)
USD |
NASDAQ |
Jan 21, 09:55
Fulcrum Therapeutics Accounts Receivable (Quarterly): 0.00 for Sept. 30, 2025
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 5.029M |
| Biogen, Inc. | 1.85B |
| CorMedix, Inc. | 158.57M |
| Apellis Pharmaceuticals, Inc. | 345.54M |
| NovaBay Pharmaceuticals, Inc. | 0.368M |